Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;25(4):297-300.
doi: 10.1016/j.annepidem.2015.01.005. Epub 2015 Jan 16.

Development of a claims-based algorithm to identify colorectal cancer recurrence

Anjali D Deshpande  1 , Mario Schootman  2 , Allese Mayer  2
Affiliations

Development of a claims-based algorithm to identify colorectal cancer recurrence

Anjali D Deshpande et al. Ann Epidemiol. 2015 Apr.

Abstract

Purpose: To examine the validity of claims data to identify colorectal cancer (CRC) recurrence and determine the extent to which misclassification of recurrence status affects estimates of its association with overall survival in a population-based administrative database.

Methods: We calculated the accuracy of claims data relative to medical records from one large tertiary hospital to identify CRC recurrence. We estimated the effect of misclassifying recurrence on survival by applying these findings to the linked Surveillance, Epidemiology, and End Results-Medicare data.

Results: Of 174 eligible CRC patients identified through medical records, 32 (18.4%) had a recurrence. A claims-based algorithm of secondary malignancy codes yielded a sensitivity of 81% and specificity of 99% for identifying recurrence. Agreement between data sources was almost perfect (kappa: 0.86). In a model unadjusted for misclassification, CRC patients with recurrence were 3.04 times (95% confidence interval: 2.92-3.17) more likely to die of any cause than those without recurrence. In the corrected model, CRC patients with recurrence were 3.47 times (95% confidence interval: 3.06-4.14) more likely to die than those without recurrence.

Conclusions: Identifying recurrence in CRC patients using claims data is feasible with moderate sensitivity and high specificity. Future studies can use this algorithm with Surveillance, Epidemiology, and End Results-Medicare data to study treatment patterns and outcomes of CRC patients with recurrence.

Keywords: Claims-based algorithm; Colorectal cancer; Misclassification; Recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any potential conflicts of interest to disclose.

References

    1. Figueredo A, Rumble RB, Maroun J, Earle CC. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26. - PMC - PubMed
    1. Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(34):8664–8670. - PubMed
    1. Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer. 2002;38(7):986–999. - PubMed
    1. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. The Annals of thoracic surgery. 2007;84(1):324–338. - PubMed
    1. Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, Schrag D, Warren JL, Hornbrook MC, Weeks JC. Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts. Med Care. 2012 - PMC - PubMed

Publication types